3 Top Genomics Stocks to Add to Your Portfolio in 2025 May 21, 2025
Regeneron and Intellia are also working together to evaluate a CRISPR gene-editing therapy targeting hemophilia. In addition, Intellia is collaborating with multiple partners in researching the use of gene-editing therapies in treating other genetic diseases, autoimmune diseases, and cancer. Several companies are using CRISPR to edit human genomes in an attempt to treat (and even […]
3 Top Genomics Stocks to Add to Your Portfolio in 2025 May 21, 2025 Read More »
